| |
| |
|
| Insider
Information: |
Ring Christine |
| Relationship: |
Chief Legal Officer |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
19,838 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,838 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nurix Therapeutics, Inc. |
NRIX |
Chief Legal Officer |
2024-04-30 |
19,838 |
2021-02-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRIX |
Nurix Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-04-30 |
4 |
S |
$12.04 |
$18,220 |
D/D |
(1,513) |
19,838 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,924 |
21,351 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-01-30 |
4 |
S |
$7.99 |
$14,063 |
D/D |
(1,760) |
17,427 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,924 |
19,187 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-10-31 |
4 |
S |
$5.20 |
$6,403 |
D/D |
(1,232) |
15,263 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,924 |
16,495 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2023-07-31 |
4 |
S |
$9.65 |
$13,710 |
D/D |
(1,420) |
12,544 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2023-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,924 |
13,964 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2023-05-01 |
4 |
S |
$9.88 |
$6,736 |
D/D |
(682) |
10,040 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2023-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,924 |
10,722 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2023-01-30 |
4 |
S |
$11.78 |
$9,989 |
D/D |
(848) |
7,261 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2023-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,924 |
8,109 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-10-31 |
4 |
S |
$12.88 |
$9,003 |
D/D |
(699) |
6,185 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,924 |
6,884 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-08-01 |
4 |
S |
$15.67 |
$11,157 |
D/D |
(712) |
4,615 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,924 |
5,327 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-05-02 |
4 |
S |
$11.75 |
$7,755 |
D/D |
(660) |
3,403 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,924 |
4,063 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-01-10 |
4 |
AS |
$27.14 |
$32,568 |
D/D |
(1,200) |
1,286 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2022-01-10 |
4 |
OE |
$1.86 |
$2,232 |
D/D |
1,200 |
2,486 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2021-12-10 |
4 |
AS |
$29.04 |
$34,848 |
D/D |
(1,200) |
1,286 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2021-12-10 |
4 |
OE |
$1.86 |
$2,232 |
D/D |
1,200 |
2,486 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2021-11-10 |
4 |
AS |
$32.38 |
$38,856 |
D/D |
(1,200) |
1,286 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2021-11-10 |
4 |
OE |
$1.86 |
$2,232 |
D/D |
1,200 |
2,486 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
General Counsel |
• – – |
2021-10-27 |
4 |
AS |
$35.25 |
$28,200 |
D/D |
(800) |
1,286 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
